Home

Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Sell · Filed 25/10/17

Trade details

Type
Insider sale
Amount
$7,020,583.19
Shares · price
414,683 sh · $16.93 a share
Held after
1,504,959 sh
Trade date
25/10/15
Filed
25/10/17
Days to filing
2 days

Sold 21.6% of holdings

Share of holding sold
21.6%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 25/09/15~25/11/14

Eric Venker's recent trades

  • Eric Venker

    Planned sale10b5-1 planRoivant Sciences

    $7.3M

    Filed 09/30

  • Eric Venker

    Planned sale10b5-1 planRoivant Sciences

    $7.1M

    Filed 08/28

  • Eric Venker

    Planned sale10b5-1 planRoivant Sciences

    $7M

    Filed 07/27

  • Eric Venker

    Sell10b5-1 planRoivant Sciences

    $5.1M

    Filed 06/26

  • Eric Venker

    Sell10b5-1 planRoivant Sciences

    $1.5M

    Filed 06/26

Eric Venker, CEO — sold $7M of Roivant Sciences ROIV · 21.6% of holdings · 10b5-1 plan | Whalegun